|
TOMM20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.660100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.228700E-04 |
| Normal-vs-Stage2 |
5.450100E-02 |
| Normal-vs-Stage3 |
1.549810E-02 |
| Normal-vs-Stage4 |
1.746980E-01 |
| Stage1-vs-Stage2 |
4.691000E-01 |
| Stage1-vs-Stage3 |
4.885800E-01 |
| Stage1-vs-Stage4 |
2.494000E-01 |
| Stage2-vs-Stage3 |
8.595200E-01 |
| Stage2-vs-Stage4 |
6.703800E-01 |
| Stage3-vs-Stage4 |
4.969400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.460630E-03 |
| Normal-vs-AfricanAmerican |
5.883000E-01 |
| Normal-vs-Asian |
1.978860E-03 |
| Caucasian-vs-AfricanAmerican |
4.058400E-03 |
| Caucasian-vs-Asian |
4.876000E-01 |
| AfricanAmerican-vs-Asian |
1.321660E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.587980E-02 |
| Normal-vs-Female |
2.122300E-03 |
| Male-vs-Female |
9.042200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.377510E-03 |
| Normal-vs-Age(41-60Yrs) |
3.002600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.869820E-01 |
| Normal-vs-Age(81-100Yrs) |
7.417800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.182400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.506400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.220400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.107030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.990800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.233000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.770400E-01 |
| Classical-VS-Follicular |
4.646400E-01 |
| Classical-VS-Other |
3.492400E-01 |
| Classical-VS-Normal |
1.345970E-02 |
| Tall-VS-Follicular |
7.042800E-01 |
| Tall-VS-Other |
6.190600E-01 |
| Tall-VS-Normal |
1.416150E-02 |
| Follicular-VS-Other |
4.984600E-01 |
| Follicular-VS-Normal |
9.017900E-03 |
| Other-VS-Normal |
6.683900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.700200E-03 |
| Normal-vs-N1 |
3.610400E-04 |
| N0-vs-N1 |
1.529400E-01 |
|
|
